CIO Leadership: Reskilling and Upskilling the Tech Workforce for the GenAI-enabled Enterprise will Pepper the Discussion at the 15th Annual Phoenix C-Level Technology Leadership Summit on March 21
January 31, 2024 11:28 ET
|
HMG Strategy
WESTPORT, Conn., Jan. 31, 2024 (GLOBE NEWSWIRE) -- HMG Strategy, the World’s #1 platform for enabling technology executives to reimagine the enterprise and reshape the business world, is thrilled to...
CIO Leadership: HMG Strategy Kicks Off its 2024 C-Level Technology Executive Leadership Summit Series with its 16th Annual Silicon Valley Global Innovation Summit on March 7
January 18, 2024 12:34 ET
|
HMG Strategy
WESTPORT, Conn., Jan. 18, 2024 (GLOBE NEWSWIRE) -- HMG Strategy, the World’s #1 platform for enabling technology executives to reimagine the enterprise and reshape the business world, is thrilled to...
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
January 16, 2024 16:01 ET
|
Celyad Oncology SA
Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...
Stem Cell Therapy Market is Expected to Reach $615 Million | MarketsandMarkets.
January 10, 2024 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Stem Cell Therapy market in terms of revenue was estimated to be worth $286 million in 2023 and is poised to reach $615 million by 2028, growing at a CAGR...
HMG Strategy’s 2023 Global Innovation Summit Recently Named as a Top Tech Conference to Attend by TechRepublic in 2023
January 05, 2024 10:35 ET
|
HMG Strategy
WESTPORT, Conn., Jan. 05, 2024 (GLOBE NEWSWIRE) -- HMG Strategy, the World's #1 digital platform for connecting business technology executives to reimagine the enterprise and reshape the business...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI
January 02, 2024 11:57 ET
|
Pomerantz LLP
NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI). Such...
DEADLINE ALERT for SEDG, BCLI, BCLYF/BCS, and OTLK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 02, 2024 10:45 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
January 02, 2024 10:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been...
BCLI FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm – BCLI
January 01, 2024 13:55 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between...
המועד האחרון הסופי לתביעה נגד BCLI מחר: רוזן, פירמת עורכי דין מהשורה הראשונה, מעודדת משקיעים ב- Brainstorm Cell Therapeutics Inc שצרו עודף הפסדים של יותר מ-500 אלף דולר להבטיח ייעוץ לפני תאריך יעד חשוב של 2 בינואר בתביעה ייצוגית בניירות ערך שהגישה החברה – BCLI
January 01, 2024 13:55 ET
|
The Rosen Law Firm PA
ניו יורק, Jan. 01, 2024 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין, משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של Brainstorm Cell Therapeutics Inc. (נאסד"ק:...